SCHEMBL12472164

SCHEMBL12472164

COC(=O)c1c(F)ccc2nc(CCNc3ncnc4c3ncn4C3CCCCO3)n(-c3ccccc3)c12

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ CYP1A2 P05177 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CYP2C19 P33261 1/20 0.38
▸ TSHR P16473 2/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ YTHDC1 Q96MU7 1/20 0.36
▸ ABL1 P00519 2/20 0.36
▸ RIN1 Q13671 2/20 0.36
▸ ADORA2A P29274 3/20 0.35
▸ ADORA3 P0DMS8 2/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ THPO P40225 1/20 0.35
▸ ADORA2B P29275 2/20 0.35
▸ FLT3 P36888 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12472163 1.00 NPC1 (0.51) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL12471799 0.93 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL12471796 0.93 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL12472673 0.89 NPC1 (0.46) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL12472675 0.89 NPC1 (0.46) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL11901248 0.85 NPC1 (0.45) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL11901249 0.85 NPC1 (0.45) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL12472949 0.83 NPC1 (0.50) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL12472950 0.83 NPC1 (0.50) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL12472340 0.81 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2673269-A1 HETEROCYCLIC COMPOUNDS AS PI3 KINASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2013-12-18 — — EP disclosed
WO-2012107465-A1 HETEROCYCLIC COMPOUNDS AS PI3 KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-08-16 — — WO disclosed
Send feedback